An Open-Label, Randomised, Placebo-Controlled, Two-Way Crossover, Phase I Single Centre Study in Type 2 Diabetes Mellitus Patients Treated With Metformin to Evaluate the Pharmacokinetics and Pharmacodynamics of Warfarin During Co-administration With AZD1656.
Phase of Trial: Phase I
Latest Information Update: 08 Nov 2010
At a glance
- Drugs AZD 1656; Warfarin
- Indications Thrombosis; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 08 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Nov 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 11 May 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.